CAMKK2 and type 2 diabetes nephropathy: Moreover, Zhong et al. (Zhong et al. 2023) demonstrated diosgenin’s efficacy in improving type 2 diabetic nephropathy by enhancing autophagy and mitochondrial dynamics via Camkk2.